Thomas James E
SEC-identified person · CIK 1204789 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Clarus Therapeutics Holdings, Inc. CRXT | Officer | filed 2021 - 2022 |
| Clarus Therapeutics INC CRXT | Officer | filed 2022 - 2022 |
| CAS Medical Systems INC CASM | Director | filed 2011 - 2019 |
| Tranzyme INC TZYM | Officer | filed 2011 - 2017 |
| Zogenix, INC. ZGNX | Officer | filed 2010 - 2010 |
| Coley Pharmaceutical Group, Inc. COLY | Director | filed 2006 - 2007 |
| Wright Medical Group INC wmgi | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.